1 INTRODUCTION

    1.1 Study Objectives
    1.2 Market Definition

        1.2.1 Telehealth
        1.2.2 Telemedicine

    1.3 Study Scope

        1.3.1 Market Segmentation & Geographical Spread
        1.3.2 Inclusions & Exclusions
        1.3.3 Years Considered
        1.3.4 Currency Considered

    1.4 Stakeholders
    1.5 Summary of Changes

2 MARKET OVERVIEW

    2.1 Introduction
    2.2 Market Dynamics

        2.2.1 Drivers

            2.2.1.1 Growing geriatric population and  increasing need for
                    advanced  healthcare infrastructure
            2.2.1.2 Rising prevalence of chronic diseases
            2.2.1.3 Reduced time and lower  out-of-pocket costs
            2.2.1.4 Advancements in  telecommunication technologies
            2.2.1.5 Shortage of skilled healthcare  professionals
            2.2.1.6 Increased government support and  favorable regulatory
                    policies
            2.2.1.7 Expansion of remote  patient monitoring systems

        2.2.2 Restraints

            2.2.2.1 High investment costs for  B2B models and lack of IT
                    expertise
            2.2.2.2 State-to-state and inter-country  regulatory variations
            2.2.2.3 Behavioral reluctance to  adopt new technologies
            2.2.2.4 Rise in fraud and abUse in  healthcare systems
            2.2.2.5 Adherence to patient privacy,  confidentiality, medical
                    ethics

        2.2.3 Opportunities

            2.2.3.1 Growing Use of wearables, applications,  and sensors for
                    virtual care
            2.2.3.2 Emergence of AI and ML
            2.2.3.3 Increasing shift toward  outpatient care models
            2.2.3.4 High utility of telemedicine against  infectious
                    communicable diseases  and epidemics
            2.2.3.5 Expansion of hospital-at-home  (HaH) initiatives
            2.2.3.6 Demand for electronic medical  record-based telehealth
                    services
            2.2.3.7 Rising incidence of mental illnesses and  growing focus on
                    emotional well-being

        2.2.4 Challenges

            2.2.4.1 Data security and confidentiality concerns
            2.2.4.2 Limited data accessibility
            2.2.4.3 Inability to maintain patient hygiene  and cleanliness
                    standards

    2.3 Trends/Disruptions Impacting Customer’s Business
    2.4 Industry Trends
    2.5 Ecosystem Analysis
    2.6 Value Chain Analysis
    2.7 Technology Analysis

        2.7.1 Key Technologies

            2.7.1.1 Video conferencing and real-time  communication platforms
            2.7.1.2 AI and ML
            2.7.1.3 Virtual assistants and chatbots
            2.7.1.4 Voice recognition and natural language  processing
            2.7.1.5 EHR integration
            2.7.1.6 Remote patient monitoring systems

        2.7.2 Complementary Technologies

            2.7.2.1 Edge computing
            2.7.2.2 Cloud computing
            2.7.2.3 Mobile health (mHealth) applications
            2.7.2.4 Wearable devices, sensors, and IoT

        2.7.3 Adjacent Technologies

            2.7.3.1 Digital therapeutics
            2.7.3.2 Blockchain technology
            2.7.3.3 Augmented reality and virtual reality

    2.8 Trade Analysis

        2.8.1 Trade Data for HSN Code 90189099

            2.8.1.1 Top 10 importers for  HSN code 90189099
            2.8.1.2 Top 10 exporters for HSN code 90189099

        2.8.2 Trade Data for HSN Code 9021

            2.8.2.1 Top 10 importers for HSN code 9021
            2.8.2.2 Top 10 exporters for HSN code 9021

        2.8.3 Trade Data for HSN Code 9022

            2.8.3.1 Top 10 importers for HSN code 9022
            2.8.3.2 Top 10 exporters for HSN code 9022

    2.9 Porter’s Five Forces Analysis

        2.9.1 Threat of New Entrants
        2.9.2 Threat of Substitutes
        2.9.3 Bargaining Power of Buyers
        2.9.4 Bargaining Power of Suppliers
        2.9.5 Intensity of Competitive Rivalry

    2.10 Patent Analysis

        2.10.1 Patent Publication Trends for  Telehealth & Telemedicine
        2.10.2 Insights: Jurisdiction and Top Applicant Analysis

    2.11 Unmet Needs & End-User Expectations

        2.11.1 Unmet Needs
        2.11.2 End-User Expectations

    2.12 Key Conferences & Events, 2025–2026
    2.13 Investment & Funding Scenario
    2.14 Business Model Analysis

        2.14.1 Direct-to-Patient (D2P) Model
        2.14.2 Business-to-Business (B2B) Model
        2.14.3 Employer-Sponsored Model
        2.14.4 Subscription-Based Model
        2.14.5 Hybrid Telemedicine Model
        2.14.6 Platform-as-a-Service (PaaS) Model
        2.14.7 Value-Based Care Model

    2.15 Impact of AI/Gen AI in Telehealth & Telemedicine Market

        2.15.1 Key Use Cases
        2.15.2 Major Case Studies

            2.15.2.1 AI to redefine treatment  effectiveness and safety
            2.15.2.2 AI-driven chatbots and telehealth to  enhance mental health
                     and chronic  disease management

        2.15.3 Impact of AI/Gen AI on Interconnected and  Adjacent Ecosystems

            2.15.3.1 Healthcare IT and EHR systems
            2.15.3.2 Pharmaceuticals & drug discovery
            2.15.3.3 Mental health tech
            2.15.3.4 Healthcare analytics and insights

        2.15.4 User Readiness & Impact Assessment

            2.15.4.1 User readiness

                2.15.4.1.1 User A: Hospitals
                2.15.4.1.2 User B: Ambulatory  surgery centers

            2.15.4.2 Impact assessment

                2.15.4.2.1 User A: Hospitals
                2.15.4.2.2 User B: Ambulatory  surgery centers

    2.16 Reimbursement Scenario Analysis

3 COMPETITIVE LANDSCAPE

    3.1 Introduction
    3.2 Key Player Strategies/Right to Win

        3.2.1 Overview of Strategies Adopted By Key Players in  Telehealth &
              Telemedicine Market

    3.3 Revenue Analysis, 2019–2023
    3.4 Market Share Analysis, 2023
    3.5 Company Evaluation Matrix: Startups/SMEs, 2023

        3.5.1 Progressive Companies
        3.5.2 Responsive Companies
        3.5.3 Dynamic Companies
        3.5.4 Starting Blocks
        3.5.5 Competitive Benchmarking: Startups/SMEs, 2023

            3.5.5.1 Detailed list of key startups/SMEs
            3.5.5.2 Competitive benchmarking of  key startups/SMEs

    3.6 Company Valuation & Financial Metrics
    3.7 Brand/Software Comparative Analysis
    3.8 Competitive Scenario

        3.8.1 Product Launches & Approvals
        3.8.2 Deals
        3.8.3 Expansions
        3.8.4 Other Developments

4 COMPANY PROFILES

    4.1 TIMEDOC, INC.

        4.1.1 Business overview
        4.1.2 Products/Solutions/Services offered
        4.1.3 Recent developments

    4.2 CEREBRAL INC.

        4.2.1 Business overview
        4.2.2 Products/Solutions/Services offered
        4.2.3 Recent developments

    4.3 KINDBODY

        4.3.1 Business overview
        4.3.2 Products/Solutions/Services offered
        4.3.3 Recent developments

    4.4 TRANSCARENT

        4.4.1 Business overview
        4.4.2 Products/Solutions/Services offered
        4.4.3 Recent developments

    4.5 CARESIMPLE INC.

        4.5.1 Business overview
        4.5.2 Products/Solutions/Services offered
        4.5.3 Recent developments

    4.6 VSEE

        4.6.1 Business overview
        4.6.2 Products/Solutions/Services offered
        4.6.3 Recent developments

    4.7 EVISIT

        4.7.1 Business overview
        4.7.2 Products/Solutions/Services offered
        4.7.3 Recent developments